Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Abbott Laboratories (ABT) had Weighted-Average Shares Outstanding (Diluted) of 1.75B for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
$11.16B |
|
$1.08B |
|
$4.89B |
|
$6.27B |
|
$9.82B |
|
$1.34B |
|
$104.00M |
|
$1.45B |
|
$1.45B |
|
$1.08B |
|
$1.08B |
|
$1.08B |
|
$1.08B |
|
$1.34B |
|
$2.15B |
|
1.74B |
|
|
Weighted-Average Shares Outstanding (Diluted) |
1.75B |
$0.62 |
|
$0.61 |
|
| Balance Sheet Financials | |
$25.51B |
|
$12.38B |
|
$84.92B |
|
$110.43B |
|
$18.38B |
|
$29.64B |
|
$39.35B |
|
$57.73B |
|
$52.70B |
|
$-395.00M |
|
$52.70B |
|
1.74B |
|
| Cash Flow Statement Financials | |
$1.31B |
|
$-20.32B |
|
$17.31B |
|
$8.52B |
|
$6.80B |
|
$-1.72B |
|
$317.00M |
|
$-1.10B |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.39 |
|
-- |
|
-- |
|
0.36 |
|
0.65 |
|
56.20% |
|
12.05% |
|
12.05% |
|
-- |
|
12.98% |
|
9.65% |
|
$916.00M |
|
-- |
|
-- |
|
-- |
|
0.10 |
|
0.70 |
|
1.36 |
|
66.19 |
|
2.04% |
|
-272.66% |
|
0.98% |
|
1.31% |
|
$30.26 |
|
$0.52 |
|
$0.75 |
|